← Current compounder rows

Current NDC auxiliary source row compounder:4767

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
26436-5622
Product Ndc
26436-5622
Product Ndc Digits
264365622
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
TIRZEPATIDE 10MG/ML
Proprietary Name Suffix
[empty]
Nonproprietary Name
TIRZEPATIDE 10MG/ML
Dosage Form Name
INJECTION, SOLUTION
Route Name
SUBCUTANEOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Hybrid Pharma
Establishment Name
Hybrid Pharma
Establishment Fei
[empty]
Substance Name
TIRZEPATIDE
Active Ingredients Info
10 mg/1 mL
History Active Ingredients Raw
TIRZEPATIDE
History Active Ingredients Info Raw
10 mg/1 mL
History Dosage Raw
INJECTION, SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
26436-5622-1
Package Ndc
26436-5622-1
Package Ndc Digits
2643656221
Package Ndc11
26436562201
Package Description
1 mL in 1 VIAL, MULTI-DOSE (26436-5622-1)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4767
Source Row Number
4767
Source Row Hash
2df4767dbcf5b75b6e726a329a937dd90d180e314c9a2750d66cfb0122abe8c8
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "26436-5622",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "TIRZEPATIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "26436-5622-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "TIRZEPATIDE 10MG/ML",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "TIRZEPATIDE 10MG/ML",
    "PACKAGEDESCRIPTION": "1 mL in 1 VIAL, MULTI-DOSE (26436-5622-1) ",
    "ACTIVEINGREDIENTSINFO": "10 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4767
Source Row Number
4767
Status Scope
package
Lookup Ndc
26436-5622-1
Lookup Ndc Digits
2643656221
Product Ndc
26436-5622
Product Ndc Digits
264365622
Package Ndc
26436-5622-1
Package Ndc Digits
2643656221
Package Ndc11
26436562201
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
2df4767dbcf5b75b6e726a329a937dd90d180e314c9a2750d66cfb0122abe8c8
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45